Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Free Report) Director Jennifer Straumins sold 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $20.59, for a total value of $2,059,000.00. Following the sale, the director now owns 1,388,529 shares in the company, valued at approximately $28,589,812.11. This represents a 6.72 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Calumet Specialty Products Partners Stock Performance
NASDAQ CLMT opened at $20.92 on Friday. Calumet Specialty Products Partners, L.P. has a 52-week low of $9.97 and a 52-week high of $25.29. The stock has a market cap of $1.80 billion, a PE ratio of -7.58 and a beta of 1.90. The firm has a 50-day moving average of $19.56 and a 200-day moving average of $17.13.
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) last issued its quarterly earnings data on Friday, November 8th. The oil and gas company reported ($1.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by ($0.59). The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $888.36 million. During the same period in the previous year, the business earned $0.03 EPS. The firm’s revenue was down 4.3% on a year-over-year basis. As a group, analysts predict that Calumet Specialty Products Partners, L.P. will post -2.87 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
A number of equities analysts recently weighed in on the stock. TD Cowen lowered their target price on shares of Calumet Specialty Products Partners from $27.00 to $26.00 and set a “buy” rating on the stock in a report on Monday, November 11th. The Goldman Sachs Group lowered their price objective on shares of Calumet Specialty Products Partners from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Monday, August 5th. HC Wainwright reiterated a “buy” rating and issued a $25.00 target price on shares of Calumet Specialty Products Partners in a research note on Monday, November 11th. Wells Fargo & Company lifted their price target on Calumet Specialty Products Partners from $25.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Finally, StockNews.com assumed coverage on Calumet Specialty Products Partners in a research note on Wednesday, October 23rd. They issued a “sell” rating on the stock. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $23.75.
Read Our Latest Stock Analysis on CLMT
Calumet Specialty Products Partners Company Profile
Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.
Featured Articles
- Five stocks we like better than Calumet Specialty Products Partners
- How to Use the MarketBeat Excel Dividend Calculator
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Where Do I Find 52-Week Highs and Lows?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Time to Load Up on Home Builders?
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.